ישראל -
עברית -
Ministry of Health
לינפארזה 100 מג
astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib
ישראל -
עברית -
Ministry of Health
לינפארזה 100 מג
astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib
ישראל -
עברית -
Ministry of Health
לינפארזה 150 מג
astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 150 mg - olaparib
ישראל -
עברית -
Ministry of Health
לינפארזה 150 מג
astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 150 mg - olaparib
ישראל -
עברית -
Ministry of Health
נקסיום טבליות 20 מג
astrazeneca (israel) ltd - esomeprazole - טבליה - esomeprazole 20 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.
ישראל -
עברית -
Ministry of Health
נקסיום טבליות 40 מג
astrazeneca (israel) ltd - esomeprazole - טבליה - esomeprazole 40 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.
ישראל -
עברית -
Ministry of Health
נקסיום טבליות 20 מג
astrazeneca (israel) ltd - esomeprazole - טבליה - esomeprazole 20 mg - esomeprazole
ישראל -
עברית -
Ministry of Health
נקסיום טבליות 40 מג
astrazeneca (israel) ltd - esomeprazole - טבליה - esomeprazole 40 mg - esomeprazole
ישראל -
עברית -
Ministry of Health
לוקלמה 10 גר
astrazeneca (israel) ltd - sodium zirconium cyclosilicate - אבקה להכנת תרחיף - sodium zirconium cyclosilicate 10 g/sachet - sodium zirconium cyclosilicate
ישראל -
עברית -
Ministry of Health
לוקלמה 5 גר
astrazeneca (israel) ltd - sodium zirconium cyclosilicate - אבקה להכנת תרחיף - sodium zirconium cyclosilicate 5 g/sachet - sodium zirconium cyclosilicate